In:
Journal of Comparative Effectiveness Research, Becaris Publishing Limited, Vol. 9, No. 10 ( 2020-07), p. 705-720
Abstract:
Aim: To perform cost–effectiveness analysis (CEA) and budget impact analysis (BIA) comparing stenting to standard medical treatment (SMT) for the management of deep venous outflow obstruction and leg ulcers from the Italian Healthcare Service perspective. Materials & methods: A Markov model was developed to project costs and quality-adjusted life-years (QALYs) over 3 years, based on data from literature combined with real-world data. Moreover, a BIA was performed comparing the current scenario (100% SMT) with increasing utilization rates of stenting over SMT from 0.5 to 5%, in the next 5 years. Results: Stenting is a cost-effective (incremental cost-utility ratio €12,388/QALY) or dominant option versus SMT, according to in-patient or day-hospital settings, respectively. Increasing use of stenting over SMT, in the next 5 years, is expected to yield additional costs of 39.5 million Euros (in-patient) or savings of 5.1 million Euros (day-hospital). Conclusion: Stenting is a cost-effective option compared with SMT for patients with deep vein occlusion and ulceration in Italy.
Type of Medium:
Online Resource
ISSN:
2042-6305
,
2042-6313
DOI:
10.2217/cer-2020-0030
Language:
English
Publisher:
Becaris Publishing Limited
Publication Date:
2020
detail.hit.zdb_id:
2669725-7
Permalink